Physician
Oncology
Dr. Jeremy S. Kortmansky, MD
|
|
Give Review
Jeremy Kortmansky practices Oncology. He attended Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19 in research and 29 in primary care medicine He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Jeremy Kortmansky is also published. He has 10 publications published. The lastest publication: "Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony...' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Phase II Study of Modified FOLFOX6 With Bevacizumab in Metastatic Gastroesophageal AdenoCarcinoma.
- A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic Cancer.
- A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenoCarcinoma.
- A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine Carcinomas.
- A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol.
- Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced...
- Bryostatin-1: a novel PKC inhibitor in clinical development.
- The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric Cancer cells.
- Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast Cancer treated with paclitaxel plus granulocyte colony...
Schools
NWU FIENBERG SCH OF MED
Thomas Jefferson University Hospital
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Memorial Sloan-Kettering Cancer Center -
Thomas Jefferson University -
Northwestern University Feinberg School of Medicine
Hospital
-
Yale-New Haven Hospital
Drug Facts
| NPI NUMBER | 1801835756 | |
| NPPES Provider LastName | KORTMANSKY | |
| NPPES Provider FirstName | JEREMY | |
| NPPES Provider ZIPCode | 065183600 | |
| NPPES Provider State | CT | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 1045.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 76.0 | |
| Percent Opioid Claims | 7.27 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801835756 |
| Last Name Of The Provider | KORTMANSKY |
| First Name Of The Provider | JEREMY |
| View All |
Similar Doctors
|
|
Dr. Thomas Fynan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen Bober-Sorcinelli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin E. Katz, MD
This Doctor is OpenDoctor Recommended.
|